source
- Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysLung cancer patients hadn't been seen as candidates for organ transplant. Now a study finds patients did well.STAT · 1mo ago↗ source
- STAT+: Europe will accelerate its review of RevMed’s drugKailera's GLP-1 pill data raises concerns, FDA clears Vera autoimmune therapy, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam TherapeuticsPrime Medicine said it had won an arbitration dispute against Beam Therapeutics, a clash that had pitted two well-backed gene-editing companies against each other.STAT · 1mo ago↗ source